3D InSight™ Oncology Drug Discovery Services

Identify novel cancer therapeutic solutions with our 3D InSight™ Oncology Drug Discovery Platform

InSphero's 3D InSight™ Oncology Drug Discovery Services for efficacy drug testing and immuno-oncology applications are designed to accelerate oncology drug discovery and help you gain greater translational insights.

Outsource your 3D tumor model development and preclinical testing of anti-cancer drugs to InSphero. We work with you to develop and implement a detailed study plan and ensure you get robust and reliable results, comprehensive reporting, and analysis of your oncology data.

  • Design a better model composed of the appropriate ratio of tumor cells, derived from a cancer cell line or PDX material, and stromal cell components
  • Test potency and efficacy of cancer drugs in a physiologically relevant 3D model that better reflects the complex biology of tumor
  • Assess single agent or combinatorial efficacy of small molecule, biological, ADC, or immunomodulatory drugs using 3D optimized endpoints
  • Evaluate infiltration of immune cells or the effect of your drug on immune-cell infiltration

Custom Tumor Model Development for Oncology Drug Discovery

Build a model with tumor and stromal components derived from cell line, PDX, or primary patient material.

Efficacy Testing

Test potency and efficacy of single drugs in advanced 3D tumor models.

Combinatorial Drug Testing

Test for synergistic effects of drug combinations in 3D InSight™ Tumor Microtissues.

Tumor Relapse Assay

Evaluate the potential for tumor recurrence following removal of drug.

Antibody Penetration

Optimize biological construct design by assessing antibody penetration into tumor microtissues.


Evaluate immune cell infiltration, tumor cell killing, and immuno-therapeutic efficacy

Find out how InSphero's tumor organoids and 3D cell culture services

can help you accelerate your oncology drug discovery testing

Get Started